Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Shortages: FDA Wants Advanced Warning; Practitioners Want Even More

This article was originally published in The Pink Sheet Daily

Executive Summary

Presenters at drug shortage workshop want estimates of the scope and severity of a pending supply interruption to obtain alternative therapies.

You may also be interested in...



User Fee Bills: After Mark-ups, How Will House And Senate Reconcile Differences?

House and Senate committee user fee bill mark-ups approaching, but drafts have differences in drug shortage, supply chain security and other proposed policy changes to reconcile.

Shortage Notification May Have Legislative Momentum Again After BIO Questions Reimbursement Fix

Preventing shortages through increased communications with manufacturers could gain the upper hand in part because creating economic incentives may prove too difficult and controversial.

“Critical” Drug List Would Be Created Under Shortages Bill

Draft bill being developed by Rep. John Carney, D-Del., also would create system to notify the public and other manufacturers of pending shortages.

Related Content

Topics

UsernamePublicRestriction

Register

PS072821

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel